The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The NSAIDs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NSAIDs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NSAIDs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell
Segment by Type
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Segment by Application
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of NSAIDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of NSAIDs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The NSAIDs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NSAIDs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NSAIDs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell
Segment by Type
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Segment by Application
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of NSAIDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of NSAIDs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 NSAIDs Market Overview
1.1 Product Overview and Scope of NSAIDs
1.2 NSAIDs Segment by Type
1.2.1 Global NSAIDs Market Value Comparison by Type (2024-2030)
1.2.2 Aspirin
1.2.3 Ibuprofen
1.2.4 Naproxen
1.2.5 Nabumetone
1.2.6 Others
1.3 NSAIDs Segment by Application
1.3.1 Global NSAIDs Market Value by Application: (2024-2030)
1.3.2 Back Pain Treatment
1.3.3 Osteoarthritis Treatment
1.3.4 Other Disease Treatment
1.4 Global NSAIDs Market Size Estimates and Forecasts
1.4.1 Global NSAIDs Revenue 2019-2030
1.4.2 Global NSAIDs Sales 2019-2030
1.4.3 Global NSAIDs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 NSAIDs Market Competition by Manufacturers
2.1 Global NSAIDs Sales Market Share by Manufacturers (2019-2024)
2.2 Global NSAIDs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global NSAIDs Average Price by Manufacturers (2019-2024)
2.4 Global NSAIDs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of NSAIDs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of NSAIDs, Product Type & Application
2.7 NSAIDs Market Competitive Situation and Trends
2.7.1 NSAIDs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest NSAIDs Players Market Share by Revenue
2.7.3 Global NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 NSAIDs Retrospective Market Scenario by Region
3.1 Global NSAIDs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global NSAIDs Global NSAIDs Sales by Region: 2019-2030
3.2.1 Global NSAIDs Sales by Region: 2019-2024
3.2.2 Global NSAIDs Sales by Region: 2025-2030
3.3 Global NSAIDs Global NSAIDs Revenue by Region: 2019-2030
3.3.1 Global NSAIDs Revenue by Region: 2019-2024
3.3.2 Global NSAIDs Revenue by Region: 2025-2030
3.4 North America NSAIDs Market Facts & Figures by Country
3.4.1 North America NSAIDs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America NSAIDs Sales by Country (2019-2030)
3.4.3 North America NSAIDs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe NSAIDs Market Facts & Figures by Country
3.5.1 Europe NSAIDs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe NSAIDs Sales by Country (2019-2030)
3.5.3 Europe NSAIDs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific NSAIDs Market Facts & Figures by Country
3.6.1 Asia Pacific NSAIDs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific NSAIDs Sales by Country (2019-2030)
3.6.3 Asia Pacific NSAIDs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America NSAIDs Market Facts & Figures by Country
3.7.1 Latin America NSAIDs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America NSAIDs Sales by Country (2019-2030)
3.7.3 Latin America NSAIDs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa NSAIDs Market Facts & Figures by Country
3.8.1 Middle East and Africa NSAIDs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa NSAIDs Sales by Country (2019-2030)
3.8.3 Middle East and Africa NSAIDs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global NSAIDs Sales by Type (2019-2030)
4.1.1 Global NSAIDs Sales by Type (2019-2024)
4.1.2 Global NSAIDs Sales by Type (2025-2030)
4.1.3 Global NSAIDs Sales Market Share by Type (2019-2030)
4.2 Global NSAIDs Revenue by Type (2019-2030)
4.2.1 Global NSAIDs Revenue by Type (2019-2024)
4.2.2 Global NSAIDs Revenue by Type (2025-2030)
4.2.3 Global NSAIDs Revenue Market Share by Type (2019-2030)
4.3 Global NSAIDs Price by Type (2019-2030)
5 Segment by Application
5.1 Global NSAIDs Sales by Application (2019-2030)
5.1.1 Global NSAIDs Sales by Application (2019-2024)
5.1.2 Global NSAIDs Sales by Application (2025-2030)
5.1.3 Global NSAIDs Sales Market Share by Application (2019-2030)
5.2 Global NSAIDs Revenue by Application (2019-2030)
5.2.1 Global NSAIDs Revenue by Application (2019-2024)
5.2.2 Global NSAIDs Revenue by Application (2025-2030)
5.2.3 Global NSAIDs Revenue Market Share by Application (2019-2030)
5.3 Global NSAIDs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer NSAIDs Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Novacap
6.2.1 Novacap Corporation Information
6.2.2 Novacap Description and Business Overview
6.2.3 Novacap NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novacap NSAIDs Product Portfolio
6.2.5 Novacap Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott NSAIDs Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer NSAIDs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson NSAIDs Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Cigna
6.6.1 Cigna Corporation Information
6.6.2 Cigna Description and Business Overview
6.6.3 Cigna NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cigna NSAIDs Product Portfolio
6.6.5 Cigna Recent Developments/Updates
6.7 Geri-Care Pharmaceuticals
6.6.1 Geri-Care Pharmaceuticals Corporation Information
6.6.2 Geri-Care Pharmaceuticals Description and Business Overview
6.6.3 Geri-Care Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Geri-Care Pharmaceuticals NSAIDs Product Portfolio
6.7.5 Geri-Care Pharmaceuticals Recent Developments/Updates
6.8 Perrigo Company
6.8.1 Perrigo Company Corporation Information
6.8.2 Perrigo Company Description and Business Overview
6.8.3 Perrigo Company NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Perrigo Company NSAIDs Product Portfolio
6.8.5 Perrigo Company Recent Developments/Updates
6.9 Kopran
6.9.1 Kopran Corporation Information
6.9.2 Kopran Description and Business Overview
6.9.3 Kopran NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Kopran NSAIDs Product Portfolio
6.9.5 Kopran Recent Developments/Updates
6.10 Merck Sharp & Dohme
6.10.1 Merck Sharp & Dohme Corporation Information
6.10.2 Merck Sharp & Dohme Description and Business Overview
6.10.3 Merck Sharp & Dohme NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Merck Sharp & Dohme NSAIDs Product Portfolio
6.10.5 Merck Sharp & Dohme Recent Developments/Updates
6.11 Sun Pharmaceutical Industries
6.11.1 Sun Pharmaceutical Industries Corporation Information
6.11.2 Sun Pharmaceutical Industries NSAIDs Description and Business Overview
6.11.3 Sun Pharmaceutical Industries NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sun Pharmaceutical Industries NSAIDs Product Portfolio
6.11.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.12 GlaxoSmithKline
6.12.1 GlaxoSmithKline Corporation Information
6.12.2 GlaxoSmithKline NSAIDs Description and Business Overview
6.12.3 GlaxoSmithKline NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 GlaxoSmithKline NSAIDs Product Portfolio
6.12.5 GlaxoSmithKline Recent Developments/Updates
6.13 Reddy Pharmaceuticals
6.13.1 Reddy Pharmaceuticals Corporation Information
6.13.2 Reddy Pharmaceuticals NSAIDs Description and Business Overview
6.13.3 Reddy Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Reddy Pharmaceuticals NSAIDs Product Portfolio
6.13.5 Reddy Pharmaceuticals Recent Developments/Updates
6.14 Verywell
6.14.1 Verywell Corporation Information
6.14.2 Verywell NSAIDs Description and Business Overview
6.14.3 Verywell NSAIDs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Verywell NSAIDs Product Portfolio
6.14.5 Verywell Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 NSAIDs Industry Chain Analysis
7.2 NSAIDs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 NSAIDs Production Mode & Process
7.4 NSAIDs Sales and Marketing
7.4.1 NSAIDs Sales Channels
7.4.2 NSAIDs Distributors
7.5 NSAIDs Customers
8 NSAIDs Market Dynamics
8.1 NSAIDs Industry Trends
8.2 NSAIDs Market Drivers
8.3 NSAIDs Market Challenges
8.4 NSAIDs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
